Publications

Guo Z, Terness P, Süsal C, and Opelz G: B lymphocytes regulate its own immune response (in German). Immunol Spektrum. 1990,6:4-7

Terness P, Süsal C, Baur C, Guo Z, and Opelz G: A B cell suppressive IgG-antiimmunogbulin antibody induced by alloimmunization. Transplantation 1990, 50:502-505

Süsal C, Guo Z, Terness P, and Opelz G: Role of anti-IgG autoantibodies in kidney transplantation. Immunol Letters 1990, 26:121-125

Terness P, Schiffl R, Süsal C, Guo Z, and Opelz G: Long lasting kidney graft survival after immunization with antibody-coated blood cells: Mediation by immunosuppressive autoantibodies. Immunol Letters, 1990, 26:139-144

Süsal C, Guo Z, Terness P, Padanyi A, Petranyi G, and Opelz G: Induction of anti-F(ab)2 antibodies by buffy coat transfusions and their effect in kidney transplantation. Transplant Proc 1990, 22:1893-1894

Terness P, Süsal C, Guo Z, and Opelz G: Fc-dependent suppression of "in vitro" B-cell response by IgG of alloimmunized rats. Transplant Proc 1990, 22:1957-1959

Mytilineos J, Guo Z, Scherer S, and Opelz G: Enhanced Chemiluminescence: A new non-radioactive labeling and detection system for polymerase chain reaction-sequence-specific oligonucleotide probe class II typing. In HLA 1991 (edited by K. Tsuiji et al.) Vol2. Oxford 1992, P306-308

Guo Z, Yang N-S, Jiao SS, Sun J, Cheng L, Wolff JA, and Duncan ID: Efficient and sustained gene transfer and expression in mature rat oligodendrocytes in primary culture. J Neuro Res 1996, 43:32-41

Guo Z*, Chong AS, Shen J, Foster P, Shankary HM, Mital D, McChesney L, Jensik S, and Williams JW: Prolongation of rat islet allograft survival by the immunosuppressive agent, leflunomide. Transplantation 1997, 63:711-716

Guo Z*, Chong AS, Shen J, Foster P, Shankary HM, Mital D, McChesney L, Jensik S, Gebel HM, and Williams JW: In vivo effects of leflunomide on normal and pancreatic islet and isogeneic islet graft function. Transplantation 1997, 63:716-721

Guo Z*, Chong AS, Shen J, Foster P, Shankary HM, Mital D, McChesney L, Jensik S, Gebel HM, and Williams JW: Leflunomide, a potential immunosuppressant for pancreatic islet transplantation. Transplant Proc 1997, 29:1296-1297

Guo Z*, Chong AS, Tian Y, Shen J, Yin D, Mital D, Foster P, Sankary H, McChesney L et al.: Effect of leflunomide and cyclosporine on concordant xenogeneic islet transplantation in streptozotocin-induced and autoimmune diabetic mice. Transplant Proc 1997, 29:2155

Guo Z*, Chong AS, Shen J, Foster P, Shankary HM, Mital D, McChesney L, Jensik S, and Williams JW: Gene gun-mediated gene transfer and expression in rat islets. Transplant Proc 1997, 29:2209

Mital D, Guo Z, Chong AS, Fu Z, Foster P, Shankary HM, Jensik S, McChesney L, Tian Y and Williams JW: Successful xenotransplantation of porcine islets in NOD and Balb/c mice with leflunomide and cyclosporine (±MALS). Transplant Proc 1997, 29:216

Guo Z*, Mital D, Shen J et al. Immunosuppression preventing concordant xenogeneic islet graft rejection is not sufficient to prevent recurrence of autoimmune diabetes in nonobese diabetic mice. Transplantation 1998; 65: 1310-1314

Guo Z*, Mital D, Shen J, Tian Y, Foster P, Shankary HM, McChesney L, Jensik S, Chong AS, and Williams JW: Effect of gene gun-mediated CTLA4Ig and Fas ligand genes transfection on concordant xenogeneic islet graft rejection. Transplant Proc 1998, 30:589

Guo Z*, Chong AS, Mital D, Shen J, Tian Y, Foster P, Shankary HM, McChesney L, Jensik S, and Williams JW: Different effect of leflunomide on concordant xenogeneic islet graft rejection and recurrence of autoimmune diabetes in NOD mice. Transplant Proc 1998, 30:463-464

Mital D, Guo Z, Y Tian, J Shen, Z, Foster P, Shankary HM, Jensik S, McChesney L, Chong A, Olack B and Williams JW: Leflunomide-based immunosuppression for porcine islet transplantation. Transplant Proc 1998, 30:515

Guo Z*, Shen J, Mital D, Hong Y, Alemany R, Zhong W-W, Jensik SC and Williams JW: Efficient gene transfer and expression in islets by an adenoviral vector that lacks all viral genes. Cell Transplantation 1999; 8: 661-671

Guo Z*, Shen J, Mital D, Hong Y, Jensik SC and Williams JW:Role of Fas in recurrence of autoimmune diabetes after islet transplantation. Transplant Proc 1999; 31: 622

Guo Z*, Shen J, Mital D, Hong Y, Jensik SC, Alemany R, Zhong W-W and Williams JW: Comparison of viral gene-deleted adenoviral vector with the E1-deleted adenoviral vector in islets. Transplant Proc 1999; 31: 794

Guo Z*, Wu T, KirchhofN, MitalD, Williams JM, Azuma M, SutherlandDER and Hering BJ: Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antigonists protects islet grafts in spontaneously diabetic NOD mice from autoimmune destruction, allogeneic and xenogeneic graft rejection. Transplantation 2001, 71:1656-1665

Wu T, Kirchhof N, Yagita H, Sutherland DER, Hering BJ and Guo Z*: The role of OX40/OX40L and CD27/CD70 pathways on allogeneic islet graft rejection. Transplant Proc 2001; 33:217-218

Hiraoka K, Trexler A, Fujioka B, Guo Z, Zhang HJ, Overland A, Oberbroeckling J, Sageshima J, Shibata S, Sutherland DER, and Hering BJ: Optimal temperature in pancreas preservation by the tow-layer cold storage method before islet isolation. Transplant Proc 2001; 33: 891-892

Shibata S, Matsumoto S, Sageshima J, Hiraoka K, Sutherland DER, Kirchhof N, Guo Z, Koyama K, Gilmore T, Dunning M, Ansite JD, Shearer, JD, Clemmings S, Hedlund BE, Sehgal SN, and Hering BJ: Temporary treatment with sirolimus and low-trough cyclosporine prevents acute allograft rejection and combination with starch-conjugated deferoxamine promotes islet engraftment in the preclinical pig model. Transplant Proc 2001; 33: 509

Wu T, Heuss N, Levay-Young B, Sozen H, Kirchof N, Sutherland DER, Hering BJ, Guo Z*: Inducing tolerance to MHC-matched allogeneic islet grafts in diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy. Transplantation 2002; 74:22-27

Wu T, Sozen H, Luo B, Heuss N, Kalscheuer H, Lan P, Sutherland DER, Hering B, Guo Z*: Rapamycin and T-cell costimulatory blockade as posttransplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy. Bone Marrow Transplant 2002; 29:949-956

Guo Z*, Wu T, Sozen H, Heuss N, Kalscheuer H, Sutherland DER, Blazar B, Hering BJ: A substantial level of mixed hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic NOD mice. Transplantation 2003; 75:909-915

Pan Y, Luo B, Sozen H, Heuss N, Kalscheuer H, Sutherland DER, Hering BJ, Guo Z*: Blockade of the CD40/CD154 pathway enhances T-cell depleting bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy. Transplantation 2003; 76:216-224

Berg T, Wuo T, Levary-Young B, Heuss N, Pan Y, Kirchhof N, Sutherland, DER, Hering B, Guo Z*: Comparison of tolerated and rejected islet grafts: A gene expression study. Cell Transplantation  2004, 13:619-629

Liu B, Hao J, Pan Y, Luo B, Westgard B, Heremans Y, Sutherland DER, Hering BJ, and Guo Z*: Increasing donor chimerism and inducing tolerance to islet allografts by posttransplant donor lymphocytes infusion. Am J Transplant  2006; 126:933-946

Luo B, Wu T, Pan Y, Sozen H, Hao J, Zhang Y, Sutherland DER, Hering BJ, and Guo Z*: Resistance to the induction of mixed chimerism in spontaneously diabetic NOD mice depends on the CD40/CD154 pathway and donor MHC disparity. Ann NY Acad Sci 2007; 1103:94-102

Tian B, Hao J, Zhang Y, Tian L, Yi Huimin, O'Brien TD, Sutherland DER, Hering BJ, and Guo Z*: Upregulating regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy. Transplantation 2009; 87:198-206

Tian L, Gao J, Hao J, Zhang Y, Yi H, O'Brien TB, Sorenson R, Luo J, and Guo Z*: Reversal of New Onset Diabetes through Modulating Inflammation and Stimulating Beta-Cell Replication in NOD Mice by a Dipeptidyl peptidase IV (DPP-IV) Inhibitor. Endocrinology 2010; 151:3049-3060

Tian L, Gao J, Weng G, Yi H, Tian B, O'Brien TB, and Guo Z*: Comparison of exendin-4 on beta cell replication in mouse and human islet grafts. Transplant International 2011; (in press)
 
Gao J, Tian L, Weng G, Bhagro NG, Sorenson RL, O'Brien TO, Luo J and Guo Z*: Stimulating beta cell replication and improving islet graft function by GPR119 agonists. Transplant International 2011; (in press)
 
Gao J, Tian L, Weng G, O'Brien TO, Luo J and Guo Z*: Stimulating beta cell replication and improving islet graft function by AR231453, a GPR119 agonist. Transplantation Proceeding 2011; (in press) 
 
Loganathan G, Dawra RK, Pugazhenthi S, Guo Z, Soltani SM, Wiseman A, Sanders MA, Papas KK, Kumaravel V,. Saluja AK, Sutherland DER, Hering BJ, Balamurugan AN. Insulin degradation by acinar-cell proteases creates a dysfunctional environment for human islets before/after transplantation: Benefits of alpha-1 antitrypsin treatment. Transplantation 2011; (in press)